DDEL-05. IMPRESSIVE RESPONSE TO IDH-INHIBITOR THERAPY IN IDH-MUTANT, H3K27M INTACT BRAINSTEM GLIOMAS
Trusha Shah(University of Washington), Vyshak Alva Venur(University of Washington Medical Center), Lynne P. Taylor(University of Washington)
Cited by 1
Related Papers
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma
|JAMA Oncology|2022|411
Central Nervous System Lymphoma
|Seminars in Neurology|2023|17
ANGI-07. GLIOBLASTOMA WITH BONY METASTATIC DISEASE IN A PATIENT WITH NEUROFIBROMATOSIS TYPE 1: A CASE REPORT
|Neuro-Oncology|2023|1
NIMG-69. FREQUENCY OF TUMOR-RELATED VASCULATURE IN PRIMARY CNS LYMPHOMA ON ROUTINE MRI
|Neuro-Oncology|2021|0